NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31

Minerva Neurosciences, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$2.32−0.03 (-1.28%)

Close on Oct 19, 2026

Market cap: $183.52M
P/E (TTM): –
Dividend yield: –

Minerva Neurosciences, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Depreciation & Amortization	0.01	0.01	0.01	–	–	0.02	0.02	0.02	0.01	0.02	0.02	0.03	–
Stock-Based Compensation	1.33	1.33	1.97	4.11	5.22	9.70	9.17	8.18	5.03	3.57	2.20	18	0.66
Deferred Income Taxes	–	–	–	–	-1.80	–	-2.25	–	-9.38	–	–	–	–
Change in Accounts Payable	-1.06	-0.20	0.84	-0.88	0.86	-1.32	0.52	0.36	-0.03	0.11	0.72	0.37	0.52
Change in Unearned Revenue	–	–	–	–	–	-41	–	–	41	2.55	-1.22	1.22	–
Operating Cash Flow	-14	-20	-15	-25	-25	-34	-43	-42	3.09	-26	-24	-36	-2.16
Capital Expenditures	–	–	–	-0.02	–	–	–	–	-0.05	–	–	-0.05	0.00
Purchase of Investments	–	–	–	–	–	-3.87	-61	-41	-135	–	-23	–	–
Sale & Maturity of Investments	–	–	–	–	–	–	–	–	27	18	4.99	–	–
Investing Cash Flow	0	0	0	-0.02	–	25	14	69	-107	18	-18	1.09	0.00
Share Repurchases	–	–	–	–	–	–	–	–	0.00	–	–	–	–
Debt Repaid	–	–	–	–	–	–	–	–	–	–	–	-1.88	–
Financing Cash Flow	74	–	20	0.00	60	13	0.52	-3.34	47	77	38	52	3.78
Net Change in Cash	61	-20	4.82	-25	35	3.94	-29	24	-57	–	–	–	–
Free Cash Flow	–	–	–	-25	–	–	–	–	3.04	–	–	-36	-2.16
Income Taxes Paid	0	0	–	–	–	–	–	–	–	–	–	–	–
Interest Paid	–	–	–	–	–	–	–	0.09	0.44	0.69	0.62	0.02	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 352.6%

Financial strength

Current ratio: 20.14
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 622.8%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –